In this Grand Rounds, Bruce Blazar, M.D., from the University of Minnesota Medical School, discusses the biological properties of regulatory T cells (Tregs) that are well suited for regaining immune homeostasis. He identifies allogeneic transplant recipients that may benefit from Treg therapies, assesses the impact of CAR Tregs on acute and autoimmune-like graft-versus-host disease, and describes the biological and outcome differences between CD4 peripheral Tregs and in vitro-induced Tregs.

Center for Individualized Medicine (CIM) Grand Rounds

Main presenter

Bruce Blazar, M.D.
Regents Professor
Department of Pediatrics
Division of Pediatric Blood and Marrow Transplant and Cellular Therapy
University of Minnesota Medical School